REXAHN PHARMACEUTICALS, INC. Stock Agreements
10 Contracts & Agreements
- Form of Restricted Stock Unit Award and Form of Award Agreement (Filed With SEC on November 1, 2023)
- Form of Stock Option Grant Notice issued under the Ocuphire Pharma, Inc. 2021 Inducement Plan (Filed With SEC on March 30, 2023)
- Contingent Value Rights Agreement, dated as of November 5, 2020, by and among the Company, Shareholder Representative Services LLC and the Olde Monmouth Stock Transfer Co., Inc (Filed With SEC on November 6, 2020)
- Description of Common Stock (Filed With SEC on February 21, 2020)
- Form of Restricted Stock Unit Agreement under the Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan (Filed With SEC on March 7, 2019)
- First Amendment to the Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan, as Amended and Restated as of June 9, 2016 (Filed With SEC on April 13, 2017)
- Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan, as Amended and Restated (Filed With SEC on June 10, 2016)
- Form of Stock Option Grant Agreement under Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan (Filed With SEC on March 14, 2016)
- Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan (Filed With SEC on June 11, 2013)
- Extension of Stock Option Agreements dated May 2, 2006 by and between Rexahn Pharmaceuticals, Inc. and John Holaday (Filed With SEC on May 5, 2006)
